TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) (WP2453)
Homo sapiens
When transported into the inner mitochondrial matrix, pyruvate encounters two principal metabolizing enzymes: pyruvate carboxylase, PC (a gluconeogenic enzyme) and pyruvate dehydrogenase (PDH), the first enzyme of the PDH complex (PDHc). With a high cell-energy charge, co-enzyme A (CoA) is highly acylated, principally as acetyl-CoA, and able to obligately activate pyruvate carboxylase, directing pyruvate toward gluconeogenesis. When the energy charge is low, CoA is not acylated, therefore, pyruvate carboxylase is inactive, and pyruvate is preferentially metabolized via the PDHc and the TCA cycle to CO2 and H2O. The acetyl-CoA produced by the PDHc enters the TCA cycle and the reduced electron carriers (NADH and FADH2) that are generated during the oxidative reactions can then be used to drive ATP synthesis via oxidative phosphorylation. Description source: [https://themedicalbiochemistrypage.org/tca-cycle.php The Medical Biochemistryp Page] Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP2453 CPTAC Assay Portal].
Authors
M Aguirre , Martina Summer-Kutmon , Kristina Hanspers , Marianthi Kalafati , Denise Slenter , Eric Weitz , and Egon WillighagenActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
- DNA methylation of ARHGAP30 is negatively associated with ARHGAP30 expression in lung adenocarcinoma, which reduces tumor immunity and is detrimental to patient survival (2021).
- A patient-based iPSC-derived hepatocyte model of alcohol-associated cirrhosis reveals bioenergetic insights into disease pathogenesis (2024).
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
Annotations
Pathway Ontology
disease pathway pyruvate decarboxylase deficiency pathway citric acid cycle pathwayLabel | Type | Compact URI | Comment |
---|---|---|---|
ThPP | Metabolite | kegg.compound:C00068 | |
Pyruvate | Metabolite | kegg.compound:C00022 | |
Isocitrate | Metabolite | kegg.compound:C00311 | |
Acetyl-CoA | Metabolite | kegg.compound:C00024 | |
2-Hydroxy-ethyl-ThPP | Metabolite | kegg.compound:C05125 | |
Oxalosuccinate | Metabolite | kegg.compound:C05379 | |
Citrate | Metabolite | kegg.compound:C00158 | |
Succinate | Metabolite | kegg.compound:C00042 | |
Oxaloacetate | Metabolite | kegg.compound:C00036 | |
Dihydro-lipoamide-E | Metabolite | chebi:80219 | |
Lipoamide-E | Metabolite | kegg.compound:C15972 | |
3-carboxy-1-hydroxypropyl-ThPP | Metabolite | pubchem.compound:440649 | |
Succinoyl-CoA | Metabolite | kegg.compound:C00091 | |
Phosphoenol-pyruvate | Metabolite | kegg.compound:C00074 | |
(S)-Malate | Metabolite | kegg.compound:C00149 | |
2-Oxo-glutarate | Metabolite | kegg.compound:C00026 | |
S-Succinyl-dihydrolipoamide-E | Metabolite | kegg.compound:C16254 | |
Fumarate | Metabolite | kegg.compound:C00122 | |
S-Acetyldihydro-lipoamide-E | Metabolite | kegg.compound:C16255 | |
DLST | GeneProduct | ensembl:ENSG00000119689 | |
DLD | GeneProduct | ensembl:ENSG00000091140 | |
ACO1 | GeneProduct | ensembl:ENSG00000122729 | |
FH | GeneProduct | ensembl:ENSG00000091483 | |
MDH1 | GeneProduct | ensembl:ENSG00000014641 | |
OGDH | GeneProduct | ensembl:ENSG00000105953 | |
IDH1 | GeneProduct | ensembl:ENSG00000138413 | |
PCK1 | GeneProduct | ensembl:ENSG00000124253 | |
ACLY | GeneProduct | ensembl:ENSG00000131473 | |
CS | GeneProduct | ensembl:ENSG00000062485 | |
SUCLG2 | GeneProduct | ensembl:ENSG00000172340 | |
PDHA1 | GeneProduct | ensembl:ENSG00000131828 | |
IDH3A | GeneProduct | ensembl:ENSG00000166411 | |
SDHA | GeneProduct | ensembl:ENSG00000073578 | |
PC | GeneProduct | ncbigene:5091 | |
DLAT | GeneProduct | ensembl:ENSG00000150768 |